Cargando…

The Value of Tumor Treating Fields in Glioblastoma

Glioblastoma (GBM) is one of the most common tumors of the central nervous system, which is the most lethal brain cancer. GBM treatment is based primarily on surgical resection, combined with radiotherapy and chemotherapy. Despite the positive treatment, progression free survival and overall surviva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chaochao, Du, Jianyang, Xu, Weidong, Huang, Haiyan, Gao, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurosurgical Society 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671789/ https://www.ncbi.nlm.nih.gov/pubmed/32380584 http://dx.doi.org/10.3340/jkns.2019.0224

Ejemplares similares

Tumor-Treating Fields in Glioblastomas: Past, Present, and Future
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Tumor treating fields in the management of Glioblastoma: opportunities for advanced imaging
por: Soni, Vikram S., et al.
Publicado: (2019)

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists
por: Burri, Stuart H., et al.
Publicado: (2018)

Tumor treating fields for the treatment of glioblastoma: Current understanding and future perspectives
por: Colamaria, Antonio, et al.
Publicado: (2023)

Current usage of tumor treating fields for glioblastoma
por: Lassman, Andrew B, et al.
Publicado: (2020)

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review
por: Fabian, Denise, et al.
Publicado: (2019)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
por: Du, Xue, et al.
Publicado: (2022)

Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)

Tumor treating fields increases membrane permeability in glioblastoma cells
por: Chang, Edwin, et al.
Publicado: (2018)

Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma
por: Lok, Edwin, et al.
Publicado: (2017)

Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023)

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022)

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
por: Omar, Ayman I.
Publicado: (2014)

Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
por: Kim, Eun Ho, et al.
Publicado: (2016)

Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic
por: Gatson, Na Tosha N., et al.
Publicado: (2021)

The Routine Application of Tumor-Treating Fields in the Treatment of Glioblastoma WHO° IV
por: Krigers, Aleksandrs, et al.
Publicado: (2022)

IL-2 TUMOR TREATING FIELDS: IMPROVING THE ODDS FOR PATIENTS WITH GLIOBLASTOMA
por: Hottinger, Andreas F
Publicado: (2022)

Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities
por: Jones, Amber B., et al.
Publicado: (2023)

Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields
por: Rulseh, Aaron Michael, et al.
Publicado: (2012)

Corrigendum to: Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
Publicado: (2022)

Tumour treating fields therapy for glioblastoma: current advances and future directions
por: Rominiyi, Ola, et al.
Publicado: (2020)

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide
por: Robins, H. Ian, et al.
Publicado: (2018)

Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
por: Palmer, Joshua D., et al.
Publicado: (2021)

Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
por: Vymazal, Josef, et al.
Publicado: (2023)

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis
por: Ballo, Matthew T., et al.
Publicado: (2023)

Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
por: Kessler, Almuth F., et al.
Publicado: (2018)

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
por: Jo, Yunhui, et al.
Publicado: (2018)

Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids
por: Ye, Eunbi, et al.
Publicado: (2021)

Tumor-Treating Field Arrays Do Not Reduce Target Volume Coverage for Glioblastoma Radiation Therapy
por: Stachelek, Gregory C., et al.
Publicado: (2019)

Malignant Evaluation and Clinical Prognostic Values of m6A RNA Methylation Regulators in Glioblastoma
por: Du, Jianyang, et al.
Publicado: (2020)

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma
por: Lacouture, Mario E., et al.
Publicado: (2020)

COT-20 Clinical experience with tumor-treating fields therapy for newly diagnosed glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2020)

Finite element analysis of Tumor Treating Fields in a patient with posterior fossa glioblastoma
por: Lok, Edwin, et al.
Publicado: (2020)

First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
por: Kassubek, Rebecca, et al.
Publicado: (2022)

The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts
por: Oberheim-Bush, Nancy Ann, et al.
Publicado: (2022)

Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids
por: Ye, Eunbi, et al.
Publicado: (2022)

Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
por: Fishman, Hila, et al.
Publicado: (2023)

Whole transcriptome and proteome analyses identify potential targets and mechanisms underlying tumor treating fields against glioblastoma
por: Xu, Shengchao, et al.
Publicado: (2022)

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
por: Guzauskas, Gregory F, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_93dc5qu124po7o6vm7ketji3r5